Inventor · Boyds, MD, US

Herren Wu

50Patents
20h-index
48Co-inventors
88Inventor score

Filing activity: Feb 10, 1999 → May 4, 2018

Most-cited inventions

PatentTitleAreaCited byStatus
US8409568B2 Mutant antibody Fc domains and fusion proteins thereof Chemistry; Metallurgy 85 Active
US8309690B2 Integrated approach for generating multidomain protein therapeutics Chemistry; Metallurgy 82 Active
US7658921B2 Molecules with extended half-lives, compositions and uses thereof Chemistry; Metallurgy 56 Active
US6656467B2 Ultra high affinity neutralizing antibodies Chemistry; Metallurgy 52 Expired
US7229619B1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Chemistry; Metallurgy 46 Expired
US6531580B1 Anti-&agr;v&bgr;3 recombinant human antibodies and nucleic acids encoding same Chemistry; Metallurgy 42 Expired
US6312693A Antibodies against human CD40 Chemistry; Metallurgy 36 Expired
US7323172B2 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Chemistry; Metallurgy 33 Expired
US7354584B2 Recombinant IL-9 antibodies Chemistry; Metallurgy 32 Expired
US7553489B2 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Chemistry; Metallurgy 32 Active
US7531169B2 High affinity anti-human IgE antibodies Emerging Cross-Sectional Technologies 31 Expired
US7179900B2 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Chemistry; Metallurgy 31 Expired
US7790655B2 Cell display of antibody libraries Chemistry; Metallurgy 28 Active
US8252284B2 High affinity, anti-human IgE antibodies Emerging Cross-Sectional Technologies 27 Active
US7635568B2 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Chemistry; Metallurgy 26 Expired
US8604171B2 High affinity, anti-human IgE antibodies Emerging Cross-Sectional Technologies 26 Active
US7740851B2 Ultra high affinity neutralizing antibodies Chemistry; Metallurgy 25 Active
US8008443B2 Modulation of antibody effector function by hinge domain engineering Chemistry; Metallurgy 24 Active
US7847082B2 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Chemistry; Metallurgy 23 Active
US8323653B2 Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease Emerging Cross-Sectional Technologies 22 Active
US8067002B2 Humanized anti-factor D antibodies Chemistry; Metallurgy 19 Active
US8153133B2 High potency recombinant antibodies and method for producing them Chemistry; Metallurgy 19 Active
US7585504B2 High affinity antibodies against HMGB1 and methods of use thereof Emerging Cross-Sectional Technologies 16 Active
US8697396B2 Modulation of antibody effector function by hinge domain engineering Chemistry; Metallurgy 15 Active
US7659374B2 Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity Physics 14 Expired

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.